What is the clinical evidence from this study?

Study design: Editorial. Population: Venous thromboembolism after joint arthroplasty. Intervention: Pharmacologic prophylaxis.

What does this research mean for the field?

Pharmacologic prophylaxis strategies for venous thromboembolism after joint arthroplasty vary widely across clinical practice guidelines due to limitations in available evidence and differing clinical priorities regarding bleeding risk. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

To evaluate clinical prophylaxis strategies for preventing postoperative venous thromboembolism in total joint arthroplasty while balancing bleeding complications.

February 21, 2018New England Journal of Medicine

Hybrid Strategy to Prevent Venous Thromboembolism after Joint Arthroplasty

View Full Paper

Ask AI

Bookmark

Key result

Pharmacologic prophylaxis strategies for venous thromboembolism after joint arthroplasty vary widely across clinical practice guidelines due to limitations in available evidence.

Population

Patients undergoing total hip and total knee replacement procedures

Design

Editorial

Authors

DGDavid GarcíaVascular Medicine

Discussion

Member takes

Implication

Different clinical practice guidelines recommend varying strategies for VTE prophylaxis after joint arthroplasty, reflecting a trade-off between preventing thrombosis and avoiding bleeding.

Key Points

To evaluate clinical prophylaxis strategies for preventing postoperative venous thromboembolism in total joint arthroplasty while balancing bleeding complications.
Evaluated clinical practice guidelines and evidence regarding pharmacologic prophylaxis after total hip and knee replacement.
Assessed trade-offs across prophylaxis regimens ranging from low-dose aspirin monotherapy to extended anticoagulation with low-molecular-weight heparin.
Substantial variability exists across major clinical practice guidelines concerning the optimal drug choice, intensity, and duration for postoperative thromboprophylaxis.
Guideline discordance reflects limitations in available trial evidence and contrasting physician priorities regarding blood clot prevention versus bleeding avoidance.

Structured PICO

Population

Patients undergoing total hip and total knee replacement procedures

Intervention

Postoperative pharmacologic prophylaxis (e.g., low-dose aspirin or low-molecular-weight heparin)

Outcome

Venous thromboembolism

Different clinical practice guidelines recommend varying strategies for VTE prophylaxis after joint arthroplasty, reflecting a trade-off between preventing thrombosis and avoiding bleeding.

Cite This Study

David García (2018) conducted an editorial in Venous thromboembolism after joint arthroplasty. Pharmacologic prophylaxis was evaluated. Pharmacologic prophylaxis strategies for venous thromboembolism after joint arthroplasty vary widely across clinical practice guidelines due to limitations in available evidence.

synapsesocial.com/papers/6aad0f92babaa8038aed7835 https://doi.org/10.1056/nejme1716534

Topics

Anticoagulation in AF

View Full Paper

Ask AI

Bookmark

Implication

Different clinical practice guidelines recommend varying strategies for VTE prophylaxis after joint arthroplasty, reflecting a trade-off between preventing thrombosis and avoiding bleeding.

Hybrid Strategy to Prevent Venous Thromboembolism after Joint Arthroplasty

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Topics

Hybrid Strategy to Prevent Venous Thromboembolism after Joint Arthroplasty

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Also Consider

Topics

Also Consider